Equities

Kringle Pharma Inc

4884:TYO

Kringle Pharma Inc

Actions
  • Price (JPY)902.00
  • Today's Change57.00 / 6.75%
  • Shares traded227.60k
  • 1 Year change+16.39%
  • Beta1.0559
Data delayed at least 20 minutes, as of Nov 25 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Sep 30 2024202420232022
ASSETS
Cash And Short Term Investments2,3132,1362,756
Total Receivables, Net578268
Total Inventory295364350
Prepaid expenses913531
Other current assets, total0.030.152.49
Total current assets2,7562,6183,208
Property, plant & equipment, net--00
Goodwill, net------
Intangibles, net------
Long term investments------
Note receivable - long term------
Other long term assets1.121.041.04
Total assets2,7572,6193,209
LIABILITIES
Accounts payable------
Accrued expenses215.212.96
Notes payable/short-term debt--00
Current portion long-term debt/capital leases------
Other current liabilities, total107204160
Total current liabilities128209163
Total long term debt--00
Total debt--00
Deferred income tax------
Minority interest------
Other liabilities, total521388257
Total liabilities649597420
SHAREHOLDERS EQUITY
Common stock119860
Additional paid-in capital2,8353,0963,058
Retained earnings (accumulated deficit)(738)(1171)(328)
Treasury stock - common(0.11)(0.08)(0.08)
Unrealized gain (loss)------
Other equity, total00.000
Total equity2,1082,0222,789
Total liabilities & shareholders' equity2,7572,6193,209
Total common shares outstanding6.815.525.38
Treasury shares - common primary issue0.000.000.00
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.